Aarti Drugs approves 3:1 bonus issue

Shares of Aarti Drugs jumped over 6%, surging over 18% in the last 2 days after the Board of Directors approved the issuance of fully paid-up bonus share. The Board of Directors at its Meeting held on August 20, 2020, has approved the issuance of fully paid up Bonus Share in the ratio of 3:1 i.e. 3 (Three) Bonus Equity Share of Rs 10 each for 1 (One) fully paid-up Equity Share of Rs 10 each.
The board has also approved the increase in authorised share capital of the company from Rs 25 crore to Rs 120 crore by creation of additional 9.5 lakh shares.

Aarti Drugs, the maker of bulk drugs and chemicals, has delivered a stellar performance during the fiscal first quarter to June 30, even as Covid-19 pandemic disrupted economic activity across the globe.
Aarti Drug’s net profit rose 281% to Rs 85.45 crore in the quarter ended June while sales rose 34% to Rs 544.67 crore in the quarter from a year ago.
The stock has seen a fantastic run, with its stock jumping 373% for the year to date, taking the gains for the last decade to 3,808%.

Disclaimer –
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.